Compare Snowflake Inc (SNOW) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snowflake Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Snowflake Inc trades at $271.99 (market cap $95.09B), while State Street SPDR S&P Biotech ETF trades at $154.49. Which is the better fit depends on your goals.
| SNOW | XBI | |
|---|---|---|
Market Cap | $95.09B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $280.16 | $164.28 |
52-Week Low | $121.11 | $85.16 |
Enterprise Value | $94.90B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
